As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Indian Vaccine Market: By Vaccine Type: BCG Vaccine, HIB Vaccine, Influenza Vaccine, Varicella Vaccine, Typhoid Vaccine, Japanese Encephalitis Vaccine, Others; Historical Market and Forecast (2016-2026); Market Dynamics; Value Chain Analysis; Price Analysis; Regulatory Framework; Competitive Landscape; Industry Events and Developments

Indian Vaccine Market Outlook

The Indian vaccine market attained a value of INR 95 billion in 2020. The market is further expected to grow at a CAGR of 18% to reach a value of approximately INR 256.5 billion by 2026.

 

Indian Vaccine Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

India is currently among the leading producers and suppliers of vaccines globally. It represents about 60% of the total vaccines supplied to UNICEF because the cost of manufacturing, as well as clinical trials in India, is comparatively lower than those in developed countries. In addition, technical advancements and improved storage facilities for the cold chain have resulted in increased vaccine production capacity in the region. The rapid development of the market can be credited to a variety of favourable factors, such as the increased investment in research and development (R&D) by government funding agencies such as the Department of Biotechnology, the Indian Medical Research Council, and the Ministry of Health and Family Welfare.

 

Properties and Applications

Vaccines are biological preparations made up of an agent analogous to an illness-causing pathogen that provides immunization against various diseases. They are delivered orally, by aerosol or through injection as a preventive measure for a variety of diseases like polio, measles, influenza, and rabies.

 

Indian Vaccine Market By Vaccine Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on the vaccine type, the Indian vaccine market can be divided into the following:

  • BCG 
  • HIB 
  • Influenza  
  • Varicella 
  • Typhoid  
  • Japanese Encephalitis 
  • Measles 
  • Tetanus Toxoid Vaccine Market  
  • Hepatitis A 
  • Rubella 
  • DPT (Diphtheria, Tetanus and Pertussis) 
  • OPV (Oral Polio Vaccine) 
  • MMR 
  • Rotavirus 
  • Hepatitis B 
  • Pneumococcal 
  • Meningococcal 
  • Rabies 
  • HPV 
  • Hexavalent 
  • Dengue 

 

Indian Vaccine Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The rapid growth of the Indian vaccine market can be contributed to a variety of favourable factors. The introduction of the Universal Immunization Program (UIP) aimed at raising immunization coverage against treatable diseases in the nation has substantially increased the market growth. In addition, with advancements in technology, the manufacturing capability of vaccines and cold chain storage facilities have been increased. The rise of a number of privately held companies in India has also positively transformed the Indian vaccine market. Such companies have made efforts to offer low-cost solutions and are gradually turning their attention to innovation in order to raise their revenues. In view of these factors, India has emerged as a global manufacturing hub for vaccines.


Competitive Landscape

The report gives a detailed analysis of the following key players in the Indian vaccine market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.           
  • Sanofi  
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Vaccine Type
Breakup by Vaccine Type BCG Vaccine, HIB Vaccine, Influenza Vaccine, Varicella Vaccine, Typhoid Vaccine, Japanese Encephalitis Vaccine, Measles Vaccine, Tetanus Toxoid Vaccine, Hepatitis A Vaccine , Rubella Vaccine, DPT (Diphtheria, Tetanus and Pertussis) Vaccine, OPV (Oral Polio Vaccine) Vaccine , MMR Vaccine , Rotavirus Vaccine, Hepatitis B Vaccine , Pneumococcal Vaccine, Meningococcal Vaccine, Rabies Vaccine, HPV Vaccine, Hexavalent Vaccine, Dengue Vaccine
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Price Analysis Historical and Forecast Price Trends- Regional
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Indian Vaccine Market Snapshot
7    Industry Opportunities and Challenges
8    Indian Vaccine Market Analysis

    8.1    Key Industry Highlights
    8.2    Indian Vaccine Historical Market (2016-2020) 
    8.3    Indian Vaccine Market Forecast (2021-2026)
    8.4    Indian Vaccine Market by Vaccine Type
        8.4.1    BCG Vaccine 
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
            8.4.1.4    Market by Prescriber
            8.4.1.5    Market by Public and Private Sector
        8.4.2    HIB Vaccine 
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
            8.4.2.4    Market by Prescriber
            8.4.2.5    Market by Public and Private Sector
        8.4.3    Influenza Vaccine 
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2016-2020)
            8.4.3.3    Forecast Trend (2021-2026)
            8.4.3.4    Market by Prescriber
            8.4.3.5    Market by Public and Private Sector
        8.4.4    Varicella Vaccine 
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2016-2020)
            8.4.4.3    Forecast Trend (2021-2026)
            8.4.4.4    Market by Prescriber
            8.4.4.5    Market by Public and Private Sector
        8.4.5    Typhoid Vaccine 
            8.4.5.1    Market Share
            8.4.5.2    Historical Trend (2016-2020)
            8.4.5.3    Forecast Trend (2021-2026)
            8.4.5.4    Market by Prescribe
            8.4.5.5    Market by Public and Private Sector
        8.4.6    Japanese Encephalitis Vaccine 
            8.4.6.1    Market Share
            8.4.6.2    Historical Trend (2016-2020)
            8.4.6.3    Forecast Trend (2021-2026)
            8.4.6.4    Market by Prescriber
            8.4.6.5    Market by Public and Private Sector
        8.4.7    Measles Vaccine 
            8.4.7.1    Market Share
            8.4.7.2    Historical Trend (2016-2020)
            8.4.7.3    Forecast Trend (2021-2026)
            8.4.7.4    Market by Prescriber
            8.4.7.5    Market by Public and Private Sector
        8.4.8    Tetanus Toxoid Vaccine 
            8.4.8.1    Market Share
            8.4.8.2    Historical Trend (2016-2020)
            8.4.8.3    Forecast Trend (2021-2026)
            8.4.8.4    Market by Prescriber
            8.4.8.5    Market by Public and Private Sector
        8.4.9    Hepatitis A Vaccine 
            8.4.9.1    Market Share
            8.4.9.2    Historical Trend (2016-2020)
            8.4.9.3    Forecast Trend (2021-2026)
            8.4.9.4    Market by Prescriber
            8.4.9.5    Market by Public and Private Sector
        8.4.10    Rubella Vaccine 
            8.4.10.1    Market Share
            8.4.10.2    Historical Trend (2016-2020)
            8.4.10.3    Forecast Trend (2021-2026)
            8.4.10.4    Market by Prescriber
            8.4.10.5    Market by Public and Private Sector
        8.4.11    DPT (Diphtheria, Tetanus and Pertussis) Vaccine 
            8.4.11.1    Market Share
            8.4.11.2    Historical Trend (2016-2020)
            8.4.11.3    Forecast Trend (2021-2026)
            8.4.11.4    Market by Prescriber
            8.4.11.5    Market by Public and Private Sector
        8.4.12    OPV (Oral Polio Vaccine) Vaccine 
            8.4.12.1    Market Share
            8.4.12.2    Historical Trend (2016-2020)
            8.4.12.3    Forecast Trend (2021-2026)
            8.4.12.4    Market by Prescriber
            8.4.12.5    Market by Public and Private Sector
        8.4.13    MMR Vaccine 
            8.4.13.1    Market Share
            8.4.13.2    Historical Trend (2016-2020)
            8.4.13.3    Forecast Trend (2021-2026)
            8.4.13.4    Market by Prescriber
            8.4.13.5    Market by Public and Private Sector
        8.4.14    Rotavirus Vaccine 
            8.4.14.1    Market Share
            8.4.14.2    Historical Trend (2016-2020)
            8.4.14.3    Forecast Trend (2021-2026)
            8.4.14.4    Market by Prescriber
            8.4.14.5    Market by Public and Private Sector
        8.4.15    Hepatitis B Vaccine 
            8.4.15.1    Market Share
            8.4.15.2    Historical Trend (2016-2020)
            8.4.15.3    Forecast Trend (2021-2026)
            8.4.15.4    Market by Prescriber
            8.4.15.5    Market by Public and Private Sector
        8.4.16    Pneumococcal Vaccine 
            8.4.16.1    Market Share
            8.4.16.2    Historical Trend (2016-2020)
            8.4.16.3    Forecast Trend (2021-2026)
            8.4.16.4    Market by Prescriber
            8.4.16.5    Market by Public and Private Sector
        8.4.17    Meningococcal Vaccine 
            8.4.17.1    Market Share
            8.4.17.2    Historical Trend (2016-2020)
            8.4.17.3    Forecast Trend (2021-2026)
            8.4.17.4    Market by Prescriber
            8.4.17.5    Market by Public and Private Sector
        8.4.18    Rabies Vaccine 
            8.4.18.1    Market Share
            8.4.18.2    Historical Trend (2016-2020)
            8.4.18.3    Forecast Trend (2021-2026)
            8.4.18.4    Market by Prescriber
            8.4.18.5    Market by Public and Private Sector
        8.4.19    HPV Vaccine 
            8.4.19.1    Market Share
            8.4.19.2    Historical Trend (2016-2020)
            8.4.19.3    Forecast Trend (2021-2026)
            8.4.19.4    Market by Prescriber
            8.4.19.5    Market by Public and Private Sector
        8.4.20    Hexavalent Vaccine
            8.4.20.1    Market Share
            8.4.20.2    Historical Trend (2016-2020)
            8.4.20.3    Forecast Trend (2021-2026)
            8.4.20.4    Market by Prescriber
            8.4.20.5    Market by Public and Private Sector
        8.4.21    Dengue Vaccine
            8.4.21.1    Market Share
            8.4.21.2    Historical Trend (2016-2020)
            8.4.21.3    Forecast Trend (2021-2026)
            8.4.21.4    Market by Prescriber
            8.4.21.5    Market by Public and Private Sector
9    Market Dynamics
    9.1    SWOT Analysis
        9.1.1    Strengths
        9.1.2    Weaknesses
        9.1.3    Opportunities
        9.1.4    Threats
    9.2    Porter’s Five Forces Analysis
        9.2.1    Supplier’s Power
        9.2.2    Buyers Power
        9.2.3    Threat of New Entrants
        9.2.4    Degree of Rivalry
        9.2.5    Threat of Substitutes
    9.3    EMR’s Key Indicators for Demand
    9.4    EMR’s Key Indicators for Price
10    Value Chain Analysis
11    Price Analysis
12    Regulatory Framework
13    Competitive Landscape

    13.1    Market Structure
    13.2    Key Players' Market Share
    13.3    Company Profiles
        13.3.1    GlaxoSmithKline plc
            13.3.1.1    Company Overview
            13.3.1.2    Product Portfolio
            13.3.1.3    Demographic Reach and Achievements
            13.3.1.4    Certifications
        13.3.2    Novartis AG
            13.3.2.1    Company Overview
            13.3.2.2    Product Portfolio
            13.3.2.3    Demographic Reach and Achievements
            13.3.2.4    Certifications
        13.3.3    Pfizer Inc.    
            13.3.3.1    Company Overview
            13.3.3.2    Product Portfolio
            13.3.3.3    Demographic Reach and Achievements
            13.3.3.4    Certifications
        13.3.4    Sanofi    
            13.3.4.1    Company Overview
            13.3.4.2    Product Portfolio
            13.3.4.3    Demographic Reach and Achievements
            13.3.4.4    Certifications
        13.3.5    Others
14    Industry Events and Developments


List of Figures and Tables

1.    Indian Vaccine Market: Key Industry Highlights, 2016 and 2026
2.    Indian Vaccine Historical Market: Breakup by Vaccine Type (INR Billion), 2016-2020
3.    Indian Vaccine Market Forecast: Breakup by Vaccine Type (INR Billion), 2021-2026
4.    Indian BCG Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
5.    Indian BCG Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
6.    Indian BCG Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
7.    Indian BCG Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
8.    Indian HIB Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
9.    Indian HIB Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
10.    Indian HIB Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
11.    Indian HIB Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
12.    Indian Influenza Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
13.    Indian Influenza Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
14.    Indian Influenza Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
15.    Indian Influenza Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
16.    Indian Varicella Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
17.    Indian Varicella Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
18.    Indian Varicella Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
19.    Indian Varicella Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
20.    Indian Typhoid Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
21.    Indian Typhoid Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
22.    Indian Typhoid Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
23.    Indian Typhoid Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
24.    Indian Japanese Encephalitis Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
25.    Indian Japanese Encephalitis Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
26.    Indian Japanese Encephalitis Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
27.    Indian Japanese Encephalitis Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
28.    Indian Measles Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
29.    Indian Measles Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
30.    Indian Measles Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
31.    Indian Measles Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
32.    Indian Tetanus Toxoid Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
33.    Indian Tetanus Toxoid Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
34.    Indian Tetanus Toxoid Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
35.    Indian Tetanus Toxoid Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
36.    Indian Hepatitis A Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
37.    Indian Hepatitis A Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
38.    Indian Hepatitis A Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
39.    Indian Hepatitis A Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
40.    Indian Rubella Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
41.    Indian Rubella Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
42.    Indian Rubella Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
43.    Indian Rubella Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
44.    Indian DPT (Diphtheria, Tetanus and Pertussis) Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
45.    Indian DPT (Diphtheria, Tetanus and Pertussis) Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
46.    Indian DPT (Diphtheria, Tetanus and Pertussis) Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
47.    Indian DPT (Diphtheria, Tetanus and Pertussis) Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
48.    Indian OPV Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
49.    Indian OPV Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
50.    Indian OPV Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
51.    Indian OPV Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
52.    Indian MMR Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
53.    Indian MMR Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
54.    Indian MMR Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
55.    Indian MMR Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
56.    Indian Rotavirus Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
57.    Indian Rotavirus Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
58.    Indian Rotavirus Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
59.    Indian Rotavirus Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
60.    Indian Hepatitis B Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
61.    Indian Hepatitis B Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
62.    Indian Hepatitis B Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
63.    Indian Hepatitis B Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
64.    Indian Pneumococcal Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
65.    Indian Pneumococcal Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
66.    Indian Pneumococcal Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
67.    Indian Pneumococcal Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
68.    Indian Meningococcal Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
69.    Indian Meningococcal Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
70.    Indian Meningococcal Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
71.    Indian Meningococcal Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
72.    Indian Rabies Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
73.    Indian Rabies Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
74.    Indian Rabies Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
75.    Indian Rabies Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
76.    Indian HPV Vaccine Historical Market: Breakup by Prescriber (INR Billion), 2016-2020
77.    Indian HPV Vaccine Market Forecast: Breakup by Prescriber (INR Billion), 2021-2026
78.    Indian HPV Vaccine Historical Market: Breakup by Public and Private Sector (INR Billion), 2016-2020
79.    Indian HPV Vaccine Market Forecast: Breakup by Public and Private Sector (INR Billion), 2021-2026
80.    Indian Vaccine Market Structure

Key Questions Answered in the Report

The Indian vaccine market reached a value of INR 95 billion in 2020. 

The market is projected to grow at a CAGR of nearly 18% in the forecast period of 2021-2026.

The market is estimated to reach a value of about INR 256.5 billion by 2026.

The major drivers of the industry include rising disposable incomes, increasing population, rising awareness, favourable government regulations, growing investments, and the rapid advancements in technology.

Increasing investments in research and development (R&D) by government-funded agencies such as the Department of Biotechnology, the Indian Medical Research Council, and the Ministry of Health and Family Welfare is expected to be a key trend guiding the growth of the industry.

The major types of vaccines in the industry are BCG, HIB, influenza, varicella, typhoid, Japanese encephalitis, measles, tetanus toxoid, hepatitis A, rubella, DPT (diphtheria, tetanus and pertussis), OPV (oral polio vaccine) , MMR, rotavirus, hepatitis B, pneumococcal, meningococcal, rabies, HPV, hexavalent, and dengue vaccines.

The leading players in the market are GlaxoSmithKline plc, Novartis AG, Pfizer Inc., and Sanofi, among others.

Analyst Review

The Indian vaccine market attained a value of INR 95 billion in 2020 driven by the growth in the investments and favourable government policies. Aided by the rapid advancements in technology, the industry is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 18%. The industry is projected to reach INR 256.5 billion by 2026.

EMR's meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on its types, the market can be segmented into BCG, HIB, influenza, varicella, typhoid, Japanese encephalitis, measles, tetanus toxoid, hepatitis A, rubella, DPT (diphtheria, tetanus and pertussis), OPV (oral polio vaccine) , MMR, rotavirus, hepatitis B, pneumococcal, meningococcal, rabies, HPV, hexavalent, and dengue vaccine. The key players in the above industry include GlaxoSmithKline plc, Novartis AG, Pfizer Inc., and Sanofi, among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER